Technology Lead, Discovery Proteomics SRF
Contact information
Iolanda Vendrell
Technologly Lead, Discovery Proteomics SRF
PhD
Iolanda Vendrell joined the Discovery Proteomics Facility at the University of Oxford in 2015, as a senior scientist in Biological Mass Spectrometry. She currently is the Technology Lead. She studied Biochemistry at the University of Barcelona and holds a PhD in Biochemistry (in the Neuroscience program) by the same University. Her interest in Proteomics and Mass Spectrometry started during her PhD. In 2007, she moved to the UK where she has been working in Proteomics labs in both Academia and Biotech companies. Over the years, Iolanda has developed an extensive expertise in using bottom up-proteomics for general discovery projects, biomarker discovery for clinical samples and post-translational modifications. Currently, one of her interest focuses on developing and implementing high-throughput proteomics platforms for clinical and non-clinical projects.
Recent publications
-
ATR-hippo drives force signaling to nuclear F-actin and links mechanotransduction to neurological disorders.
Journal article
Chatzifrangkeskou M. et al, (2025), Sci Adv, 11
-
Cyclin F-EXO1 axis controls cell cycle-dependent execution of double-strand break repair.
Journal article
Yang H. et al, (2024), Sci Adv, 10
-
High-throughput mass spectrometry maps the sepsis plasma proteome and differences in patient response.
Journal article
Mi Y. et al, (2024), Sci Transl Med, 16
-
Proximity proteomics reveals UCH-L1 as an essential regulator of NLRP3-mediated IL-1β production in human macrophages and microglia.
Journal article
Liang Z. et al, (2024), Cell Rep, 43